Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria (Q35677457)
Jump to navigation
Jump to search
scientific article published on 2 December 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria |
scientific article published on 2 December 2011 |
Statements
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria (English)
Ann E McCullough
Monica M Reinholz
Kathleen S Tenner
Nancy E Davidson
Julie Gralow
Lyndsay N Harris
Leila A Kutteh
David W Hillman
Robert B Jenkins
2 December 2011
1 reference
1 reference
1 reference
1 reference